Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantitative p21(waf-1)/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators.

International journal of cancer - 20 Mar 2001

Ceccarelli C, Santini D, Chieco P, Lanciotti C, Taffurelli M, Paladini G, Marrano D

Abstract excerpt

We used image cytometry to quantify the immunohistochemical expression of p21(waf-1) and p53 in primary breast carcinoma. Ratio analysis of the quantified p53/p21(waf-1) protein expression allowed us to define 3 groups of carcinomas, each characterized by specific pathological and biological prof...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Ductal, Breast
Share to Carcinoma, Medullary
Share to Cyclin-Dependent Kinase Inhibitor p21

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclins

Share to Ki-67 Antigen

Share to Lymphatic Metastasis

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 11241324
DOI: 10.1002/1097-0215(20010320)95:2<128::aid-ijc1022>3.0.co;2-d

Genes

PGR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-11241324-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

Quantitative p21(waf-1)/p53 immunohistochemical analysis defines groups of primary invasive breast carcinomas with different prognostic indicators.PMID 11241324Read ↗

Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis.Semantic proximity Read ↗

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival.Semantic proximity Read ↗

p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours.Semantic proximity Read ↗

p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function.Semantic proximity Read ↗

p21 expression predicts outcome in p53-null ovarian carcinoma.Semantic proximity Read ↗

p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinic-pathological correlations.Semantic proximity Read ↗

Relations between immunologically different p53 forms, p21(WAF1) and PCNA expression in ovarian carcinomas.Semantic proximity Read ↗

P21WAF1/Cip1 gene expression in primary human hepatocellular carcinoma and its relationship with P53 gene mutation.Semantic proximity Read ↗

[WAF1/CIP1/p21 gene in wild type p53 and mutant p53 human breast cancer cell lines in relation to its cytobiological features].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.